In vivo evaluation of lipid-based formulations for oral delivery of apomorphine and its diester prodrugs.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International journal of pharmaceutics

• Publication date

  2016-11-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2016.09.024PMID 27615708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apomorphine and its esters: Differences in Caco-2 cell permeability and chylomicron affinity.

  2016cited by this paper
• Lipophilic prodrugs of apomorphine I: preparation, characterisation, and in vitro enzymatic hydrolysis in biorelevant media.

  2015cited by this paper
• Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: in vitro, rat in situ and human in vivo studies.

  2015cited by this paper
• Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.

  2014cited by this paper
• Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).

  2014cited by this paper
• Lipid-based formulations for oral administration of poorly water-soluble drugs.

  2013cited by this paper
• Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation.

  2013cited by this paper
• In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.

  2013cited by this paper
• Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations.

  2011cited by this paper
• Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies

  2010cited by this paper
• New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs

  2010cited by this paper
• Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.

  2009cited by this paper
• Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs.

  2008cited by this paper
• Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

  2007cited by this paper
• Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds.

  2007cited by this paper
• Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update

  2007cited by this paper
• Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study

  2007cited by this paper
• A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid‐based formulations in the anaesthetised rat model

  2006cited by this paper
• Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug.

  2005cited by this paper
• Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.

  2005cited by this paper
• The digestion of dietary triacylglycerols.

  2004cited by this paper
• Dopamine depletion impairs precursor cell proliferation in Parkinson disease

  2004cited by this paper
• Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion.

  2003cited by this paper
• A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration.

  2003cited by this paper
• New insights into the oxidation pathways of apomorphine

  2002cited by this paper
• Apomorphine for Parkinson’s Disease

  2002cited by this paper
• [Apomorphine in treatment of Parkinson's disease with fluctuations].

  1999cited by this paper
• Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract.

  1999cited by this paper
• Subcutaneous apomorphine in late stage Parkinson’s disease: a long term follow up

  1998cited by this paper
• Influence of lipolysis on drug absorption from the gastro-intestinal tract

  1997cited by this paper
• Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.

  1996cited by this paper
• Requirement of vascular integrin alpha v beta 3 for angiogenesis.

  1994cited by this paper
• The effect of oral dose volume on the absorption of a highly and a poorly water soluble drug in the rat

  1994cited by this paper
• Pharmacokinetics of apomorphine in parkinsonian patients

  1993cited by this paper
• Absorption of apomorphine by various routes in parkinsonism

  1991cited by this paper
• Determination of gastric-emptying profiles in the rat: influence of oil structure and volume

  1982cited by this paper
• Diester derivatives as apomorphine prodrugs.

  1976cited by this paper

• About the impact of hydrophilic organic solvents on the emulsifying properties of self-emulsifying drug delivery systems (SEDDS).

  2025cites this paper
• Apomorphine: past, present and future in Parkinson's disease and beyond.

  2025cites this paper
• In Vitro Digestion-In Situ Absorption Setup Employing a Physiologically Relevant Value of the Membrane Surface Area/Volume Ratio for Evaluating Performance of Lipid-Based Formulations: A Comparative Study with an In Vitro Digestion-Permeation Model.

  2024cites this paper
• Oral drug delivery: Influence of mucus on cellular interactions and uptake of lipid-based nanocarriers in Caco-2 cells.

  2023cites this paper
• Self-emulsifying Drug Delivery System for Praziquantel with Enhanced Ex Vivo Permeation

  2022cites this paper
• Investigation of Self-Emulsifying Drug-Delivery System Interaction with a Biomimetic Membrane under Conditions Relevant to the Small Intestine

  2021cites this paper
• Pengembangan Self-Nano Emulsifying System (SNES) Ekstrak Temulawak (Curcuma xanthorrhiza): Formulasi, Karakterisasi, dan Stabilitas

  2021cites this paper
• A comprehensive study of the basic formulation of supersaturated self-nanoemulsifying drug delivery systems (SNEDDS) of albendazolum

  2021cites this paper
• Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs

  2021cites this paper
• Solubility and Bioavailability of Fenofibrate Nanoformulations

  2020cites this paper
• Physiologically Based Pharmacokinetic Models Predicting Renal and Hepatic Concentrations of Industrial Chemicals after Virtual Oral Doses in Rats.

  2020cites this paper
• Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface.

  2020cites this paper
• Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Improved Oral Bioavailability of Chlorpromazine: In Vitro and In Vivo Evaluation

  2019cites this paper
• Sistemas de entrega de fármacos autoemulsificables: una plataforma de desarrollo alternativa para la industria farmacéutica colombiana

  2019cites this paper
• Armamentarium of nanoscaled lipid drug delivery systems customized for oral administration: In silico docking patronage, absorption phenomenon, preclinical status, clinical status and future prospects.

  2018cites this paper
• Plasma and Hepatic Concentrations of Chemicals after Virtual Oral Administrations Extrapolated Using Rat Plasma Data and Simple Physiologically Based Pharmacokinetic Models.

  2018cites this paper
• Lipidic prodrug approach for improved oral drug delivery and therapy

  2018cites this paper
• Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems

  2018cites this paper
• Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD.

  2018cites this paper
• In vivo fate of lipid-silybin conjugate nanoparticles: Implications on enhanced oral bioavailability.

  2017cites this paper
• Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease

  2017cites this paper
• Microemulsion-Based Mucoadhesive Buccal Wafers: Wafer Formation, In Vitro Release, and Ex Vivo Evaluation

  2017cites this paper
• Efficacy of oral lipid‐based formulations of apomorphine and its diester in a Parkinson's disease rat model

  2017cites this paper
• New Symptomatic Treatments for the Management of Motor and Nonmotor Symptoms of Parkinson's Disease.

  2017cites this paper